186 related articles for article (PubMed ID: 24180231)
1. Synthesis of 2-hydroxypropyl-β-cyclodextrin/pluronic-based polyrotaxanes via heterogeneous reaction as potential Niemann-Pick type C therapeutics.
Mondjinou YA; McCauliff LA; Kulkarni A; Paul L; Hyun SH; Zhang Z; Wu Z; Wirth M; Storch J; Thompson DH
Biomacromolecules; 2013 Dec; 14(12):4189-97. PubMed ID: 24180231
[TBL] [Abstract][Full Text] [Related]
2. Impact of Mixed β-Cyclodextrin Ratios on Pluronic Rotaxanation Efficiency and Product Solubility.
Mondjinou YA; Hyun SH; Xiong M; Collins CJ; Thong PL; Thompson DH
ACS Appl Mater Interfaces; 2015 Nov; 7(43):23831-6. PubMed ID: 26502827
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and evaluation of pluronic-based β-cyclodextrin polyrotaxanes for mobilization of accumulated cholesterol from Niemann-Pick type C fibroblasts.
Collins CJ; McCauliff LA; Hyun SH; Zhang Z; Paul LN; Kulkarni A; Zick K; Wirth M; Storch J; Thompson DH
Biochemistry; 2013 May; 52(19):3242-53. PubMed ID: 23560535
[TBL] [Abstract][Full Text] [Related]
4. Polyrotaxane-based systemic delivery of β-cyclodextrins for potentiating therapeutic efficacy in a mouse model of Niemann-Pick type C disease.
Tamura A; Yui N
J Control Release; 2018 Jan; 269():148-158. PubMed ID: 29138063
[TBL] [Abstract][Full Text] [Related]
5. β-Cyclodextrin-threaded biocleavable polyrotaxanes ameliorate impaired autophagic flux in Niemann-Pick type C disease.
Tamura A; Yui N
J Biol Chem; 2015 Apr; 290(15):9442-54. PubMed ID: 25713067
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of the Anionic Hydroxypropyl-β-cyclodextrin:Poly(decamethylenephosphate) Polyrotaxane and Evaluation of its Cholesterol Efflux Potential in Niemann-Pick C1 Cells.
Egele K; Samaddar S; Schneider N; Thompson D; Wenz G
J Mater Chem B; 2019 Jan; 7(4):528-537. PubMed ID: 31372225
[TBL] [Abstract][Full Text] [Related]
7. [Intracellularly Degradable Polyrotaxanes for Therapeutic Applications].
Tamura A
Yakugaku Zasshi; 2019; 139(2):143-155. PubMed ID: 30713223
[TBL] [Abstract][Full Text] [Related]
8. Pluronic based β-cyclodextrin polyrotaxanes for treatment of Niemann-Pick Type C disease.
Collins CJ; Loren BP; Alam MS; Mondjinou Y; Skulsky JL; Chaplain CR; Haldar K; Thompson DH
Sci Rep; 2017 Apr; 7():46737. PubMed ID: 28452365
[TBL] [Abstract][Full Text] [Related]
9. Structure-function relationships of cholesterol mobilization from the endo-lysosome compartment of NPC1-deficient human cells by β-CD polyrotaxanes.
Samaddar S; Bose D; Loren BP; Skulsky JL; Ilnytska O; Struzik ZJ; Storch J; Thompson DH
PLoS One; 2022; 17(12):e0268613. PubMed ID: 36584173
[TBL] [Abstract][Full Text] [Related]
10. Efficient pDNA Delivery Using Cationic 2-Hydroxypropyl-β-Cyclodextrin Pluronic-Based Polyrotaxanes.
Badwaik V; Mondjinou Y; Kulkarni A; Liu L; Demoret A; Thompson DH
Macromol Biosci; 2016 Jan; 16(1):63-73. PubMed ID: 26257319
[TBL] [Abstract][Full Text] [Related]
11. Lysosomal-specific cholesterol reduction by biocleavable polyrotaxanes for ameliorating Niemann-Pick type C disease.
Tamura A; Yui N
Sci Rep; 2014 Mar; 4():4356. PubMed ID: 24619155
[TBL] [Abstract][Full Text] [Related]
12. Differential Effects of 2-Hydroxypropyl-Cyclodextrins on Lipid Accumulation in
Hoque S; Kondo Y; Sakata N; Yamada Y; Fukaura M; Higashi T; Motoyama K; Arima H; Higaki K; Hayashi A; Komiya T; Ishitsuka Y; Irie T
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019132
[TBL] [Abstract][Full Text] [Related]
13. Structure-property relationship for in vitro siRNA delivery performance of cationic 2-hydroxypropyl-β-cyclodextrin: PEG-PPG-PEG polyrotaxane vectors.
Badwaik VD; Aicart E; Mondjinou YA; Johnson MA; Bowman VD; Thompson DH
Biomaterials; 2016 Apr; 84():86-98. PubMed ID: 26826298
[TBL] [Abstract][Full Text] [Related]
14. Differential mode of cholesterol inclusion with 2-hydroxypropyl-cyclodextrins increases safety margin in treatment of Niemann-Pick disease type C.
Yamada Y; Ishitsuka Y; Kondo Y; Nakahara S; Nishiyama A; Takeo T; Nakagata N; Motoyama K; Higashi T; Arima H; Kamei S; Shuto T; Kai H; Hayashino Y; Sugita M; Kikuchi T; Hirata F; Miwa T; Takeda H; Orita Y; Seki T; Ohta T; Kurauchi Y; Katsuki H; Matsuo M; Higaki K; Ohno K; Matsumoto S; Era T; Irie T
Br J Pharmacol; 2021 Jul; 178(13):2727-2746. PubMed ID: 33782944
[TBL] [Abstract][Full Text] [Related]
15. Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells.
Rosenbaum AI; Zhang G; Warren JD; Maxfield FR
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5477-82. PubMed ID: 20212119
[TBL] [Abstract][Full Text] [Related]
16. Investigation of 2-Hydroxypropyl-β-Cyclodextrin Treatment in a Neuronal-Like Cell Model of Niemann-Pick Type C Using Quantitative Proteomics.
Cougnoux A; Pergande MR; Serna-Perez F; Cologna SM
J Am Soc Mass Spectrom; 2023 Apr; 34(4):668-675. PubMed ID: 36920149
[TBL] [Abstract][Full Text] [Related]
17. In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β-Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C.
Yasmin N; Ishitsuka Y; Fukaura M; Yamada Y; Nakahara S; Ishii A; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Okada Y; Nishikawa J; Ichikawa A; Iohara D; Hirayama F; Higaki K; Ohno K; Matsuo M; Irie T
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845767
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of 2-hydroxyalkylated β-cyclodextrins as potential therapeutic agents for Niemann-Pick Type C disease.
Kondo Y; Tokumaru H; Ishitsuka Y; Matsumoto T; Taguchi M; Motoyama K; Higashi T; Arima H; Matsuo M; Higaki K; Ohno K; Irie T
Mol Genet Metab; 2016 Jul; 118(3):214-219. PubMed ID: 27184436
[TBL] [Abstract][Full Text] [Related]
19. Oligo(ethylene glycol)-modified β-cyclodextrin-based polyrotaxanes for simultaneously modulating solubility and cellular internalization efficiency.
Tamura A; Ohashi M; Yui N
J Biomater Sci Polym Ed; 2017; 28(10-12):1124-1139. PubMed ID: 28299982
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable Polyester of Poly (Ethylene glycol)-sebacic Acid as a Backbone for β -Cyclodextrin-polyrotaxane: A Promising Gene Silencing Vector.
Ghodke S; Mahajan P; Gupta K; Ver Avadhani C; Dandekar P; Jain R
Curr Gene Ther; 2019; 19(4):274-287. PubMed ID: 31393245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
